Cancer Patients and Recurrent P's

There's a lot of growing evidence that systemic thrombolysis for an intermediate group increases harm without necessarily increasing any benefit. So these are ones where they're a little bit tacky maybe you've got slightly raised your opponent so you are concerned about them but there's no hypertension and there are other as well we need to just be treating them with low molecularly heparins or doax potentially inpatient admission.